Drug Co-Pay Subsidies From Pharma At Odds With Goals Of Health Reform - Medco
This article was originally published in The Pink Sheet Daily
Executive Summary
From a health care reform perspective, the industry's increasing practice of providing subsidies that help keep patients on higher cost drugs "is a really bad thing to do" and "should not be allowed," Chairman Snow comments during PBM's earnings call.